Erytech Pharma SA, Lyon, France (NYSE EURON EXT: ERYP)
A biopharmaceutical company developing innovative cancer therapies aimed at starving tumour growth. The Company’s proprietary technology is based on the encapsulation of therapeutic molecules into red blood cells.
Raise private mezzanine financing round to fund clinical trials initiative in the United States and enable the Company to pursue an Initial Public Offering.
Recordati S.p.A. (BIT: REC), an international pharmaceutical group focused on primary care and orphan drugs for the treatment of rare diseases.
€5,000,000 convertible note as part of a licensing and distribution agreement with Orphan Europe, a wholly owned subsidiary of Recordati S.p.A.
Acted as financial advisor to the Board of Directors and management
- Prepared marketing materials and compiled electronic data room
- Designed targeted fund raising campaign approaching financial and corporate investors.
- Advised the Company investment terms and transaction structure.
